In contrast, the targeted deep-sequencing assay called Deeplex Myc-TB (GenoScreen, Lille, France) targets full sequences (i.e. coding sequence plus part of promoter region) or (most) relevant regions of 18 MTBC drug resistance-associated genes, combined with genomic targets for mycobacterial species identification and MTBC strain genotyping. This evidence concerns the gene MYC and tuberculosis.